Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 26/08/19971 min de leitura
Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The NADA provides for intramuscular injection of polysulfated glycosaminoglycan for dogs for control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →